Expanded Access for Relatlimab

Sponsor
Bristol-Myers Squibb
Study ID
NCT05170659
Status
No Longer Available

Eligibility Criteria

Sex
All
Age
N/A - N/A
Healthy Volunteers
Not accepted

Interventions

Study Details

This is an expanded access designed to provide access to Relatlimab for eligible participants.

Key Dates

Status verified
Apr 2022